Reinhold G Erben Selected Research

Lactose

1/2018	Lack of vitamin D signalling per se does not aggravate cardiac functional impairment induced by myocardial infarction in mice.
11/2016	Fgf23 and parathyroid hormone signaling interact in kidney and bone.
4/2012	Long-term Fgf23 deficiency does not influence aging, glucose homeostasis, or fat metabolism in mice with a nonfunctioning vitamin D receptor.
1/2012	Klotho lacks a vitamin D independent physiological role in glucose homeostasis, bone turnover, and steady-state PTH secretion in vivo.
3/2007	Ablation of vitamin D signaling rescues bone, mineral, and glucose homeostasis in Fgf-23 deficient mice.
3/2003	Impaired insulin secretory capacity in mice lacking a functional vitamin D receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Reinhold G Erben Research Topics

Disease

11	Chronic Renal Insufficiency 10/2022 - 01/2011
9	Osteoporosis 01/2012 - 01/2003
8	Hyperphosphatemia 07/2017 - 11/2004
7	Bone Resorption 01/2017 - 08/2002
7	Body Weight (Weight, Body) 02/2015 - 08/2002
6	Secondary Hyperparathyroidism 10/2022 - 07/2002
5	Hypophosphatemia 07/2022 - 11/2004
5	Myocardial Infarction 01/2021 - 10/2015
4	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2022 - 01/2014
4	Hypertension (High Blood Pressure) 12/2022 - 01/2014
4	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 10/2022 - 11/2004
4	Cardiomegaly (Heart Hypertrophy) 01/2021 - 06/2014
4	Hyperplasia 09/2015 - 09/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2020 - 01/2011
3	Rickets (Rachitis) 04/2016 - 07/2002
3	Osteomalacia 04/2016 - 01/2012
3	Hypercalcemia (Milk Alkali Syndrome) 10/2014 - 08/2002
3	Atrophy 01/2012 - 11/2004
2	Vitamin D Deficiency 12/2022 - 01/2018
2	Heart Failure 12/2022 - 09/2020
2	Wasting Syndrome (Wasting Disease) 10/2022 - 01/2018
2	Atherosclerosis 12/2020 - 09/2020
2	Hypocalcemia 11/2016 - 03/2003
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2015 - 11/2013
2	Metabolic Bone Diseases (Osteopenia) 01/2013 - 08/2002
2	Premature Aging 04/2012 - 01/2012
2	Insulin Resistance 01/2012 - 03/2007
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022
1	Hypertrophy 07/2022
1	Diabetes Mellitus 01/2021
1	Infarction (Infarctions) 01/2021
1	Ischemia 01/2021
1	Reperfusion Injury 01/2021
1	Sepsis (Septicemia) 01/2021
1	Ischemic Stroke 12/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2020
1	Osteolysis 10/2020
1	Chronic Kidney Disease-Mineral and Bone Disorder (Renal Rickets) 01/2018
1	Cicatrix (Scar) 01/2018
1	Neuroinflammatory Diseases 04/2017
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2017
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2017

Drug/Important Bio-Agent (IBA)

13	Vitamin D FDA LinkGeneric 12/2022 - 08/2002
12	Phosphates (Orthophosphate)IBA 10/2022 - 11/2004
12	CalciumIBA 10/2020 - 03/2003
10	Fibroblast Growth Factor-23IBA 07/2022 - 11/2004
9	MineralsIBA 01/2021 - 03/2003
6	Hormones (Hormone)IBA 10/2022 - 10/2015
6	Lactose FDA LinkGeneric 01/2018 - 03/2003
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 07/2002
5	Phosphorus (Red Phosphorus)IBA 01/2018 - 03/2003
4	Calcitriol Receptors (Calcitriol Receptor)IBA 10/2020 - 01/2009
4	LigandsIBA 01/2018 - 12/2009
4	Parathyroid Hormone (Parathormone)IBA 11/2016 - 12/2009
3	AldosteroneIBA 07/2022 - 12/2017
3	SodiumIBA 10/2017 - 09/2015
3	Actins (F Actin)IBA 10/2012 - 07/2005
3	salicylhydroxamic acid (SHAM)IBA 07/2012 - 05/2008
3	deoxypyridinolineIBA 07/2012 - 05/2009
3	Glucose (Dextrose)FDA LinkGeneric 04/2012 - 03/2007
2	Atrial Natriuretic Factor (ANF)IBA 07/2022 - 01/2021
2	OsteoprotegerinIBA 01/2018 - 08/2009
2	CytokinesIBA 01/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 01/2018 - 04/2017
2	Estrogens (Estrogen)FDA Link 01/2017 - 04/2009
2	EndopeptidasesIBA 04/2016 - 07/2005
2	1,25-dihydroxyvitamin DIBA 10/2014 - 11/2011
2	Insulin (Novolin)FDA Link 04/2012 - 01/2012
2	Estradiol (Delestrogen)FDA LinkGeneric 04/2012 - 11/2004
2	hydroxide ionIBA 11/2011 - 12/2006
2	GlucocorticoidsIBA 08/2009 - 05/2009
2	Denosumab FDA Link 08/2009 - 05/2009
2	Calcitriol (Calcijex)FDA LinkGeneric 11/2004 - 08/2002
1	PHEX Phosphate Regulating Neutral EndopeptidaseIBA 10/2022
1	antineoplaston A10 (A 10)IBA 07/2022
1	CanrenoneIBA 07/2022
1	Angiotensin Receptor AntagonistsIBA 07/2022
1	Losartan (Cozaar)FDA LinkGeneric 07/2022
1	Mineralocorticoid Receptor AntagonistsIBA 07/2022
1	etelcalcetide hydrochlorideIBA 01/2021
1	AlloxanIBA 01/2021
1	ThioredoxinsIBA 01/2021
1	Natriuretic PeptidesIBA 01/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	RANK LigandIBA 01/2018
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2018
1	Mitochondrial Uncoupling ProteinsIBA 04/2017
1	Uncoupling Protein 1IBA 04/2017
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2017
1	Adenine FDA LinkGeneric 01/2017
1	Estrogen Receptor alphaIBA 01/2017

Therapy/Procedure

4	Therapeutics 01/2015 - 01/2009
2	Nephrectomy 01/2017 - 02/2015
2	Stents 09/2015 - 05/2012
2	Ovariectomy (Oophorectomy) 11/2010 - 04/2009
1	Renal Dialysis (Hemodialysis) 01/2021
1	Ligation 01/2021
1	Punctures 01/2021
1	Percutaneous Coronary Intervention 01/2021